Scientists artificially infect mosquitoes with malaria in bid to help eradicate the disease

0:00
play article
Subscribers can listen to this article
In 2019, there were an estimated 229 million malaria cases and 409 000 deaths - mostly babies - around the world. (iStock)
In 2019, there were an estimated 229 million malaria cases and 409 000 deaths - mostly babies - around the world. (iStock)
  • Researchers have infected mosquitoes with the human malaria parasite.
  • It might take up to 15 years before a new drug is developed to fight malaria. 
  • Researchers say this paves the way for malaria eradication. 

Scientists at the University of the Witwatersrand (Wits) have infected mosquitoes with malaria, discovering new compounds that might be a breakthrough in the treatment of the disease. 

Scientists at the Wits Research Institute for Malaria (WRIM) in partnership with the University of Pretoria and colleagues in the US, Spain, and Switzerland, have identified novel antiplasmodial lead compounds that could be used for mass drug administration and vector control to eliminate malaria.

The study's findings were published in the journal Nature Communications this week.

Professor Lizette Koekemoer, co-director of WRIM and the National Research Foundation SARChI Chair in Medical Entomology and Control, who co-authored the research paper, said the team established a mosquito malaria infection centre at the Faculty of Health Sciences at Wits University, where the mosquito transmission blocking experiments took place.

READ HERE | SA team makes breakthrough in the fight against malaria – using TB, anti-cancer meds

"The WRIM infection centre is the only facility in South Africa and in the southern African region that can artificially infect mosquitoes with the human malaria parasite. The infection centre provided the high level of expertise required to infect mosquitoes with the human malaria parasite and allowed for this unique study to be done," she said. 

Ten days after infection, the mosquito guts were removed and the number of malaria parasites counted and compared against those mosquitoes that received only an infected blood meal without treatment. The researchers found the ability to transmit the disease was decreased in mosquitoes infected with the parasite.

READ | Missed malaria diagnosis leads to man's death

Koekemoer said: "Normally, how a mosquito is able to transmit malaria is that it has to feed on somebody who has [the] malaria parasite. This can be someone who carries the malaria parasite, but is not sick. The female mosquito will feed on somebody with the malaria parasite and then when that mosquito 12 to 14 days later bites someone else, she can then transmit the disease."

Their research now meant that if someone with the malaria parasite was given a drug with the compound, the mosquito would not be able to spread the disease to other people.

"What will happen is that you will now have to screen the community to see if they have malaria parasites in their bloodstream. You can do this very quickly with a blood test. If you then see that the person carries the malaria parasite, you then give them a prophylactic drug or a treatment drug and the parasite will then be cleared from the human. Mosquitoes will still come feed on that person, but just won't be able to transmit the disease,"  Koekemoer said.  

READ HERE | Five targets the WHO wants to meet in 2021

She said while it was still early days, the research paved way for the eradication of malaria. 

"It's very early days, but it is very nice that we have the expertise here now in this country for future studies. The compound that has been identified at this lab phase will then go further. We need to make sure they are safe for humans.

"Normally a drug, it doesn't matter for what disease, can take up to 15 years in development. We are looking at a five to 10 year period, unfortunately. But I think it is good to not rush things," she said. 

In 2019, there were an estimated 229 million malaria cases and 409 000 deaths - mostly babies - around the world, according to the World Health Organisation. 

ALSO READ | After malaria and Covid-19, British man survives cobra bite in India

On why it was so hard to fight malaria, Koekemoer said: "It's a multifactorial disease because you need the human and then the mosquito and the parasite. In most situations it's difficult to control malaria because either the area where it occurs is very rural and sending the controls to the people is very challenging.

"In Africa, we know that political stability is a big thing. You need money. South Africa has a great malaria programme, but it costs money and other African countries don't have the resources to do that. They depend on donor funding that comes with conditions."


Did you know you can comment on this article? Subscribe to News24 and add your voice to the conversation.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
Lockdown For
DAYS
HRS
MINS
Voting Booth
How has the delay in schools' opening impacted your life?
Please select an option Oops! Something went wrong, please try again later.
Results
It's a disaster! We're struggling to manage work and kids at home
40% - 1063 votes
It's a struggle, but we learnt lessons from last year's closures
20% - 530 votes
It's a relief, this second wave is bad and kids need to be at home
40% - 1077 votes
Vote
ZAR/USD
15.08
(+0.34)
ZAR/GBP
20.67
(+0.16)
ZAR/EUR
18.36
(+0.32)
ZAR/AUD
11.67
(+0.08)
ZAR/JPY
0.15
(+0.28)
Gold
1750.60
(-3.00)
Silver
25.47
(-0.26)
Platinum
1098.50
(+0.09)
Brent Crude
54.99
(0.00)
Palladium
2358.50
(+0.17)
All Share
64341.55
(+0.55)
Top 40
59177.40
(+0.49)
Financial 15
11711.32
(+0.22)
Industrial 25
86890.90
(+0.36)
Resource 10
63337.04
(+1.02)
All JSE data delayed by at least 15 minutes morningstar logo